Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Hair loss gene linked to prostate issues.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Finasteride treats hair loss and reduces prostate cancer risk.

Higher serum androgens contribute to male pattern baldness.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Androgen receptors help prostate cancer cells grow and resist drugs.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.